Edition:
United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

505.50DKK
4:59am EST
Change (% chg)

kr.-4.50 (-0.88%)
Prev Close
kr.510.00
Open
kr.510.00
Day's High
kr.510.00
Day's Low
kr.505.00
Volume
39,681
Avg. Vol
345,535
52-wk High
kr.594.00
52-wk Low
kr.434.30

Chart for

About

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for... (more)

Overall

Beta: 1.01
Market Cap(Mil.): kr.100,980.00
Shares Outstanding(Mil.): 198.00
Dividend: 10.50
Yield (%): 2.94

Financials

  Industry Sector
P/E (TTM): -- 51.22 15.79
EPS (TTM): -- -- --
ROI: -- 13.48 12.01
ROE: -- 20.00 15.91

UPDATE 5-Earnings drag on European shares, Credit Suisse shines

* Credit Suisse, Danske Bank are bright spots (Recasts, adds quote and detail, updates prices at close)

Nov 02 2017

Shares in Coloplast plummet after new strategy disappoints

Nov 2 Shares in Danish healthcare products maker Coloplast fell more than 10 percent on Thursday, after the company gave up its long-term target to improve its EBIT margin every year.

Nov 02 2017

BRIEF-Coloplast sees 2017/2018 revenue growth at lower end of long-term outlook

* Q4 REVENUE DKK 3.98‍​ BILLION (REUTERS POLL DKK 4.02 BILLION)

Nov 02 2017

Coloplast got scrapes from Greek and French pricing reforms, shares fall

Aug 16 Coloplast's third quarter results disappointed investors as pricing reforms in France and Greece hit the Danish healthcare product maker harder than expected.

Aug 16 2017

BRIEF-Coloplast Q3 EBIT, revenue below forecast

* CONTINUE TO EXPECT 2016/17 ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES

Aug 16 2017

Earnings vs. Estimates